| July 19, 2010 | Immunacia's Genetic Immunity Reports Phase II Data on DermaVir, a Therapeutic Vaccine for HIV/AIDS, During the XVIII International AIDS Conference: A 70% Viral Load Reduction Demonstrated in HIV Drug-naïve Individuals ( Click here to read the press release... ) | |
|---|---|---|
| July 12, 2010 | Immunacia's Genetic Immunity Presents DermaVir at the 7th International Conference on Nanosciences & Nanotechnologies ( Click here to read the press release... ) | |
| May 3, 2010 | Dr. James Chafouleas Joins ViroStatics and Genetic Immunity as Strategic Adviser ( Click here to read the press release... ) | |
| March 02, 2010 | Genetic Immunity Presents DermaVir at DNA Vaccines 2010 Conference ( Click here to read the press release... ) | |
| June 11, 2009 | Genetic Immunity InPlay: Company completes patient enrollment in Phase II trial of DermaVir Patch HIV immunotherapeutic nanomedicine lead product candidate ( Click here to read the press release... ) | |
| May 13, 2009 | Genetic Immunity InPlay: Company to present at the Bio International Convention in Atlanta ( Click here to read the press release... ) | |
| April 23, 2009 | Genetic Immunity InPlay: Company to attend CLINAM European Conference for Clinical Nanomedicine ( Click here to read the press release... ) | |
| April 16, 2009 | Genetic Immunity InPlay: Second Phase II clinical trial commences in Italy on Company's lead product candidate DermaVir Patch HIV vaccine ( Click here to read the press release... ) | |
| April 01, 2009 | Genetic Immunity, InPlay - Genetic Immunity licenses plasmid DNA purification technology ( Click here to read the press release... ) | |
| March 11, 2009 | Genetic Immunity, InPlay - Genetic Immunity receives CE marking for DermaPrep, a unique transdermal drug delivery device ( Click here to read the press release... ) | |
| March 04, 2009 | Genetic Immunity, Retrospective - Phase I trial results for the Company's HIV vaccine candidate lead product ( Click here to read the press release... ) | |
| February 26, 2009 | Genetic Immunity, Retrospective - Next generation DNA vaccine - DermaVir nanomedicine for the treatment of HIV-AIDS ( Click here to read the press release... ) | |
| February 23, 2009 | Power of the Dream Ventures signs business development agreement with Genetic Immunity ( Click here to read the press release... ) | |
| November 13, 2008 BusinessWire | Genetic Immunity's Press Release: Genetic Immunity® Announces First Patient Dosed In Phase II Trial With DermaVir Patch For HIV Disease ( Click here to read the press release... ) | |
| September 10, 2008 Vaccine | Genetic Immunity's Press Release: IL-15 as memory T-cell adjuvant for topical HIV-1 DermaVir vaccine ( Click here to read the press release... ) | |
| June 12, 2008 BusinessWire | Genetic Immunity's Press Release: Genetic Immunity to Present at 2008 BIO International Convention ( Click here to read the press release... ) | |
| June 12, 2008 BusinessWire | Genetic Immunity's Press Release: Genetic Immunity to Partner with the ITDH to Promote Hungarian Biotech at 2008 BIO International Convention ( Click here to read the press release... ) | |
| May 09, 2008 | Genetic Immunity's Press Release: Genetic Immunity To Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference ( Click here to read the press release... ) | |
| April 18, 2008 | Genetic Immunity's Press Release: Genetic Immunity Announces Data Related to the DermaVir Nanomedicine Patch in the Journal of Immunology - Data Supports Use of HIV-specific T cell Precursors with High Proliferative Capacity (PHPC) Marker to Predict Reduction of Viral Load ( Click here to read the press release... ) | |
| February 11, 2008 | Genetic Immunity's Press Release: Genetic Immunity Presents Clinical Data on DermaVir Patch Immune Therapy at 15th Annual Conference on Retroviruses and Opportunistic Infections - Data Shows Excellent Safety Profile and Long Lasting Immunity ( Click here to read the press release... ) | |
| February 01, 2008 | Genetic Immunity's Press Release: Genetic Immunity Announces the Appointment of Richard B. Pollard, M.D. as Chief Medical Officer - Dr. Pollard Brings the Highest Level of Clinical Immunology Expertise ( Click here to read the press release... ) | |
| October 10, 2007 BusinessWire | Genetic Immunity's Press Release: GENETIC IMMUNITY CLOSES $2 MILLION DOLLAR BRIDGE FINANCING Company Announces Engagement of Rodman & Renshaw as Financial Advisor ( Click here to read the press release... ) | |
| January 22, 2007 Internet | Recommendation of the Parliamentary Assembly of the Council of Europe: "...address the development and testing of medicines specifically for use in children living with HIV, and new technologies such as microbicides and HIV/AIDS vaccines" ( Click here to read the press release... ) | |